Valuation
- Market cap
- 10,763,000
- Revenue TTM
- $6,520,000
- Net income TTM
- $-14,670,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -225.00%
- Debt to equity
- -0.82
Trading
- Volume
- 107,300
- Avg volume
- 71,332
- Day's range
- $0.08 – $0.08
- Shares out
- 137,993,000
- Stochastic %K
- 13%
- Beta
- 0.57
- Analysts
- Strong Sell
- Price target
- $0.92
Company profile
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
- Industry
- Medical Devices
- Sector
- Healthcare
- Website
- https://www.conavi.com/novasight/
- Address
- 293 Lesmill Road, Toronto, Canada
Latest news
No headlines yet.
